Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: ACS Nano. 2018 Feb 22;12(3):2292–2310. doi: 10.1021/acsnano.7b07281

Figure 4.

Figure 4.

Cytotoxicity (LDH activity; a) and airway damage (total protein; b) markers in collected BAL fluid following pre- and post-incinerated organomodified nanoclay pulmonary exposure. Different letters indicate those treatments significantly different from each other (p < 0.05, n = 8).